Cleared Traditional

K862610 - ULTRA-VUE SPINAL TYPE BIOPSY NEEDLE

K862610 is an FDA 510(k) clearance for ULTRA-VUE SPINAL TYPE BIOPSY NEEDLE, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 211-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1987
Decision
211d
Days
Class 2
Risk

K862610 is an FDA 510(k) clearance for the ULTRA-VUE SPINAL TYPE BIOPSY NEEDLE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on February 4, 1987 after a review of 211 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K862610

510(k) Number K862610 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 1986
Decision Date February 04, 1987
Days to Decision 211 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d slower than avg
Panel avg: 129d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 695
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K862610.
ULTIMATE PROTECTIVE SAFETY CAP (UPS CAP)
K871142 · Peachtree Medical, Inc. · Jun 1987
FNA THYROID BIOPSY KIT
K870863 · Flint Laboratories Div. Travenol · May 1987
A+MED DISPOSABLE NEEDLE
K870193 · Can-Am Surgical Corp. · Feb 1987
RYMCO STERILE SINGLE-USE NEEDLE/SINGLE USE SYRINGE
K864310 · Rymco Ltda · Jan 1987
BUTTERFLY NON-CORING NEEDLE SET
K863606 · Cormed, Inc., Sub. C.R.Bard, Inc. · Dec 1986
PROMEDICOR
K863514 · Terra Marketing Assoc. · Sep 1986